Jubilant Pharmova Ltd - 530019 - Shareholder Meeting / Postal Ballot-Scrutinizer"s Report
Outcome of Postal Ballot - Scrutinizer''s Report and Voting Results25-01-2024
Jubilant Pharmova Ltd - 530019 - Shareholder Meeting / Postal Ballot-Scrutinizer"s Report
Outcome of Postal Ballot - Scrutinizer''s Report and Voting ResultsJubilant Pharmova Ltd - 530019 - Board Meeting Intimation for Intimation Of Board Meeting
Jubilant Pharmova Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/02/2024 ,inter alia, to consider and approve Board Meeting Intimation for unaudited standalone and consolidated financial results of the Company for the Quarter and Nine months ended December 31, 2023Jubilant Pharmova Ltd - 530019 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation regarding the Loss of Share CertificateJubilant Pharmova Ltd - 530019 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation regarding the issuance of letter of confirmation pursuant to the loss of share certificate.Jubilant Pharmova Ltd - 530019 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018Jubilant Pharmova Ltd - 530019 - Announcement under Regulation 30 (LODR)-Acquisition
Disclosure under Regulation 30 of the SEBI (LODR) Regulations 2015Jubilant Pharmova Ltd - 530019 - Submission Of Copies Of Newspaper Advertisement For Postal Ballot
Submission of copies of newspaper advertisement for postal ballot.Jubilant Pharmova Ltd - 530019 - Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
Notice of postal ballotJubilant Pharmova Ltd - 530019 - Closure of Trading Window
Intimation regarding closure of trading windowJubilant Pharmova Ltd - 530019 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Compliance under regulation 39(3) of intimation of details of loss of share certificate.